Mumbai February 28, 2014:- Pharma major Ranbaxy, which has been in the midst of several US FDA related issues, will exit the Nifty along with debt laden Jaiprakash Associates.
Tech Mahindra, yet another another tech stock will be added to the Nifty along with United Spirits from March 28. The addition of Tech Mahindra will now increase the weightage of technology stocks in the index.
There has been no rationale offered for the changes, but, Tech Mahindra and United Spirits have been seeing heavy volumes in the last few months. Ranbaxy has seen its share price fall significantly after a number of its plants received US FDA warning letters.
Jaiprakash Associates on the other hand is saddled with debt and its share prices has slumped in the last few years.
The CNX Nifty Junior is also undergoing a change and accordingly Tech Mahindra, United Spirits and IDBI Bank will exit the index and Ranbaxy Laboratories, ING Vysya Bank and Bharti Infratel will be included.
The CNX 100 and the CNX 200 have also undergone changes.
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…